Tpg Inc (TPG) 2026 Annual Meeting

BA BRIEFING·
Tpg Inc (TPG) 2026 Annual Meeting
14 directors up · 12 in watch zone · 4 proposals · Uncontested
$16.1B mkt cap · 1Y TSR -9.1% · Board C
Director Elections (14) · 14 of 14 scored by BA forecast
Election Outlook
Most directors look set to be re-elected without meaningful dissent — 2 of 14 scored nominees are rated Healthy. 12 are flagged for elevated vote pressure; the most-loaded are Todd Sisitsky (prior 98.8%, forecast Elevated), Anilu Vazquez-Ubarri (prior 99.3%, forecast Elevated), and Kelvin Davis (prior 99.2%, forecast Elevated), with 9 other(s) in the table below.
NomineeForecastBackground
Not independent
WATCH
Prior 99.3%
70808793100
James Coulter is a Founding Partner of TPG since 1992, serving as Executive Chair and Co-CEO, and has held board positions at Seagate Technology and Lenovo Group.
Not independent
WATCH
Prior 99.4%
70808793100
Winkelried has been CEO of TPG since 2021 and previously served as Co-CEO from 2015, with over 27 years at Goldman Sachs, including President and Co-COO.
Not independent
ELEVATED
Prior 98.8%
70808793100
Todd Sisitsky has been President of TPG Inc. since its inception and co-leads TPG Capital's healthcare investments, with notable roles in companies like IQVIA Holdings and Allogene Therapeutics.
Not independent
ELEVATED
Prior 99.3%
70808793100
Anilu Vazquez-Ubarri is a founding member of TPG and served as Chief Human Resources Officer before becoming Chief Operating Officer, with prior experience as Global Head of Talent at Goldman Sachs.
Not independent
ELEVATED
Prior 99.2%
70808793100
Kelvin Davis co-founded Colony Capital, LLC and served as its President and COO before joining TPG in 2000, where he led the North American Buyout Group until 2009.
Not independent
ELEVATED
Prior 99.0%
70808793100
Nehal Raj is a Co-Managing Partner at TPG Capital, leading investment activities in software and enterprise technology, and has served on the board of C3 in the last five years.
Not independent
ELEVATED
Prior 97.7%
70808793100
Co-Managing Partner of TPG Capital and TPG Healthcare Partners, with board roles at LifeStance Health Group and previously at AfterNext HealthTech Acquisition Corp.
Not independent
ELEVATED
Prior 97.7%
70808793100
Ganendran Sarvananthan is the Managing Partner and Co-Head of Asia at TPG Capital, overseeing a $31 billion portfolio while previously leading investments at Khazanah Nasional Berhad.
Not independent
ELEVATED
Prior 98.9%
70808793100
David Trujillo is a Co-Managing Partner at TPG and led significant investments in Airbnb, OpenAI, and Spotify, while serving on the board of Uber Technologies, Inc.
Independent
WATCH
Prior 99.2%
70808793100
Gunther Bright served as Executive Vice President and General Manager at American Express from 2014 to 2023 and currently sits on the boards of Ally Financial and McAfee Corp.
Independent
ELEVATED
Prior 98.8%
70808793100
Mary Cranston has served on the boards of The Chemours Company, Visa Inc., and McAfee Corp., and retired as Firm Senior Partner and Chair Emeritus of Pillsbury Winthrop Shaw Pittman LLP.
Independent
HEALTHY
Prior 99.8%
70808793100
Kathy Elsesser retired from Goldman Sachs in 2023 after over three decades, serving as Global Chair of the Consumer Retail and Healthcare Groups in Investment Banking.
Independent
HEALTHY
First-time at this board · prior vote history at other boards
William H. McRaven is a retired U.S. Navy Four-Star Admiral and former Chancellor of the University of Texas System, currently serving on the board of ConocoPhillips.
Independent
ELEVATED
Prior 99.0%
70808793100
Deborah M. Messemer served as Managing Partner of KPMG's Bay Area and Northwest region until 2018 and currently sits on the boards of PayPal Holdings and Allogene Therapeutics.
Proposals on the Ballot (4)
#1
Election of Directors
Filed by the board · Board recommends For
Elect the 14 director nominees named in the proxy statement, each to serve a one-year term expiring at the 2027 annual meeting.
#2
Election of Members of the Executive Committee
Filed by the board · Board recommends For
Elect the nine nominees named in the proxy statement to the Board’s Executive Committee, each for a one-year term expiring at the 2027 annual meeting.
Detail ›
This management proposal asks stockholders to elect nine members to the board’s Executive Committee for one-year terms. Management seeks approval to fill the Executive Committee because, prior to the Sunset contemplated in the Company’s governance plan, the Executive Committee shares substantial governance authority with the full board and plays a central role in overseeing the firm’s business and many operational matters. The filing emphasizes continuity and selection based on particular experience and qualifications; the board unanimously recommends a vote FOR the nominees on the basis that they possess the skills and experience necessary to execute the Company’s strategy. Of note in the company’s governance context, the Executive Committee has historically exercised many of the board’s powers (subject to certain reserved matters), and the governance plan contemplates a transition (the "Sunset") to a majority-independent board by 2027, which will affect the Committee’s future role. Electing the nominated management-aligned members preserves current governance arrangements and continuity during the transition period while the Control Group continues to select committee and board nominees. The proposal therefore has implications for control and oversight: a vote FOR sustains the existing management-led oversight structure through the next year, while a vote AGAINST would signal shareholder dissatisfaction but, given the Control Group structure and GP LLC voting power prior to the Sunset, likely would not change committee composition absent broader governance changes. The board supports the slate as part of its stated governance plan to incrementally transition to a majority independent board and to maintain operational stability. From a risk and governance perspective, investors should weigh the benefits of continuity and the nominees’ qualifications against the Company’s controlled-company structure and timeline for increasing independent oversight.
#3
Advisory Vote on Executive Compensation (Say-on-Pay
Filed by the board · Board recommends For
Non-binding advisory vote to approve the compensation paid to the Company’s named executive officers for fiscal 2025.
Detail ›
This management proposal requests an advisory (non-binding) shareholder vote to approve the Company’s executive compensation program for fiscal 2025, as disclosed in the proxy statement. Management seeks this endorsement to confirm that its pay practices — a mix of base salary, significant equity awards (RSUs and PRSUs), partner distributions, and performance-allocation-based compensation — are aligned with stockholder interests and long-term value creation. The Compensation Committee and the board emphasize pay-for-performance, citing metrics such as fee-related earnings (FRE), FRE Margin, AUM and fund performance as linkages between pay and firm outcomes; they also explain governance processes including independent Compensation Committee oversight and use of external consultants. The proxy discloses notable elements of 2025 pay (special long-term awards to the Executive Chair and Chief Legal Officer, discretionary allocations, and sizable distributions under partnership programs), explaining why these were awarded and how they are intended to align incentives and retain key leaders. The company stresses risk-mitigation features — multi-year vesting, clawback policies, side-by-side investments and restrictive covenants — to counter concerns about excessive short-term risk-taking. Because the vote is advisory, a FOR vote signals stockholder support and can validate the board’s approach; a significant vote AGAINST would prompt the Compensation Committee to consider stockholder feedback when setting future pay. The board’s stated recommendation to vote FOR rests on its view that the program balances competitiveness, alignment with performance, talent retention, and appropriate governance oversight; shareholders should therefore evaluate both the governance context (including the controlled-company structure and transition plan) and the detailed disclosures about special awards and partnership distributions when voting.
#4
Ratification of Deloitte & Touche LLP as Independent Registered Public Accounting Firm
Filed by the board · Board recommends For
Ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending .
Top institutional holders · as of Mar 31, 2026
Holder% of sharesPosition value
Temasek Holdings (Private) Ltd2.61%$406M
DARLINGTON PARTNERS CAPITAL MANAGEMENT, LP2.34%$365M
WELLINGTON MANAGEMENT GROUP LLP1.86%$289M
MILLENNIUM MANAGEMENT LLC1.72%$268M
VANGUARD PORTFOLIO MANAGEMENT LLC1.63%$254M
VANGUARD CAPITAL MANAGEMENT LLC1.58%$246M
Capital International Investors1.32%$206M
BlackRock, Inc.0.91%$142M
CITADEL ADVISORS LLC0.86%$135M
T. Rowe Price Investment Management, Inc.0.83%$129M
Source: SEC 13F filings (latest quarter). Position value is the holder’s reported aggregate value at the as-of date.
Recent key filings
Quarterly report (10-Q)View ›
Definitive proxy (DEF 14A)View ›
Annual report (10-K)View ›
Quarterly report (10-Q)View ›
Quarterly report (10-Q)View ›
Definitive proxy (DEF 14A)View ›
About the risk forecast

The risk forecast scores each director on the company’s slate against Boardroom Alpha’s YoY Director-Vote Forecast model — three XGBoost classifiers that estimate the probability the director’s vote support falls below 70%, 80%, and 90% at the upcoming annual meeting, augmented by a five-rule governance escalation layer (overboarding, audit-committee composition, prior dissent, and others).

Bands map to those probability thresholds:

  • Crisis — high probability of vote support below 70%. Rare.
  • Material — high probability of below 80%. The primary screening threshold.
  • Elevated — significant elevated risk of dissent.
  • Watch — even a mild withhold is detectable. Informational.
  • Healthy — no signal of meaningful dissent.

Prior is the director’s most-recent vote-support percentage at this same board. Direction compares the forecast to that prior vote: ↑ expected better means more support than last year; ↓ expected worse means less.

Forecast applies only to non-contested annual proxies (DEF 14A). Contested situations are tracked separately on the contested-proxy pipeline. The model is retrained nightly; bands shown reflect the most recent run.

« Back to Shareholder Meeting Calendar

Get this in your inbox
Activism and governance research, in your inbox
Director nominee slates, proposals, settlement campaigns, and AGM outcomes from US public companies.

Frequently Asked Questions

When is the Tpg Inc 2026 annual meeting?
Tpg Inc (TPG) holds its 2026 annual shareholder meeting on June 3, 2026.
What is the record date for the Tpg Inc 2026 meeting?
The record date for the Tpg Inc 2026 meeting is April 8, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Tpg Inc's 2026 meeting?
The board is presenting 14 director nominees at the Tpg Inc 2026 meeting. The full slate appears in the 'Director Nominees' table on this page, with independence designations and a structured indexable summary.
What proposals will shareholders vote on at the Tpg Inc 2026 meeting?
Shareholders will vote on 4 proposals at the Tpg Inc 2026 meeting. The full list with proposed-by tags and management recommendations appears in the 'Proposals on the Ballot' section on this page.
Are any directors at risk at Tpg Inc's 2026 annual meeting?
The Boardroom Alpha Director-Vote Forecast flags 12 of 14 scored nominees as facing elevated vote pressure at the Tpg Inc 2026 meeting: James Coulter, Jon Winkelried, Todd Sisitsky, Anilu Vazquez-Ubarri, Kelvin Davis plus 7 other(s). The most-loaded nominee is Todd Sisitsky (forecast band: elevated). Prior support: 98.8%. See the 'Director Nominees' table for the per-director forecast bar and prior support.
Where do I find the original proxy filing?
The 'View proxy' link at the top of this page opens the original SEC DEF 14A (or amended) filing for the Tpg Inc 2026 meeting in the Boardroom Alpha filing viewer.

Last updated: